Ftse Mib
32.917,87
0,77%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
66.465,35
-0,26%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Verrica Parmaceuticals Inc (VRCA) Verrica Parmaceuticals Inc (VRCA) Notizie

VRCA

Verrica Parmaceuticals (VRCA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VRCA
DataOraFonteTitoloSimboloCompagnia
10/06/202422:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
07/06/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202422:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202414:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
29/02/202414:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202316:28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
22/07/202301:28Dow Jones NewsStocks to Watch: AMC Entertainment, Becton Dickinson and Verrica PharmaceuticalsNASDAQ:VRCAVerrica Parmaceuticals Inc
21/07/202323:05Dow Jones NewsVerrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA ApprovalNASDAQ:VRCAVerrica Parmaceuticals Inc
12/06/202315:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
08/06/202322:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202314:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202314:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314:51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314:46Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VRCAVerrica Parmaceuticals Inc
06/03/202315:41Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
22/02/202322:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/02/202320:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
20/12/202212:10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/11/202212:15TipRanksH.C. Wainwright Remains a Buy on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/11/202202:48TipRanksRBC Capital Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202223:23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202222:05GlobeNewswire Inc.Verrica Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
31/08/202222:30GlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
12/08/202212:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202222:35TipRanksNeedham Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202213:30GlobeNewswire Inc.Verrica Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
05/08/202218:18PR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
03/08/202211:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VRCA

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network